Press release
May 18, 2026
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
Elanco Animal Health Inc (ELAN)
Not Found The requested URL "/press-releases/press-releases-details/2026/Elanco-Launches-Befrena-tirnovetmab-New-Anti-IL-31-Monoclonal-Antibody-a-Breakthrough-Addition-to-the-1-3-Billion-U-S--Canine-Dermatology-Market/default.aspx" was not found on this server.